Back

ChineseCVD: a web-based Chinese-specifi c cardiovascular risk calculator incorporating long COVID, COVID-19vaccination, SGLT2i and PCSK9i treatment effects

30 August 2024 (11:00 - 11:50)
Organised by: Logo
Congress Presentation Part of: Epidemiology and risk factors in cardiovascular disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Gary Tse

Hong Kong Metropolitan University, Hong Kong (China)

7 More presentations in this session

Presentation thumbnail
Ethnic variations in post ST elevation myocardial infarction inflammatory kinetics
Doctor M. Sadler (London, GB)
Abstract Slides Video
Presentation thumbnail
Standard modifiable risk factors (SMuRF) paradox for the prognosis in the patients with acute myocardial infarction
Doctor A. Takasaki (Tsu, JP)
Abstract Slides Video
Presentation thumbnail
Which is better for predicting and discriminating cardiovascular events: a traditional risk score, a calcium score or a genetic risk score?
Doctor F. Sousa (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Sex differences in clinical characteristics, phenotypes, management, and long-term outcomes of myocardial injury: an international cohort study
Mr C. Spagnuolo (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Age stratified differences in coronary artery plaque phenotype in women and men with non-obstructive coronary artery disease
Doctor C. Berge Hondros (Bergen, NO)
Abstract Slides Video

Access the full session

Session thumbnail
Epidemiology and risk factors in cardiovascular disease

The Event

Event poster

ESC Congress 2024

30 August 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Validation of cardiovascular risk prediction in chinese adults (P-CARDIAC) with territory-wide data
thumbnail
Congress Presentation
PowerAI-CVD: Chinese-specific artificial intelligence-powered predictive model for cardiovascular disease
thumbnail
Congress Presentation
Population prevalence of ECG abnormalities and risk of incident CVD outcomes: 5-year follow-up of 25,000 Chinese adults

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources